Acute HIV infection

Search with Google Search with Bing
Information
Disease name
Acute HIV infection
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT03711253 Active, not recruiting Phase 4 Empiric Treatment for Acute HIV in the ED October 14, 2019 June 1, 2023
NCT03579381 Completed Specimen Repository for HIV Immunopathogenesis July 31, 2017 January 25, 2019
NCT00734344 Completed N/A Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection September 2008 September 2012
NCT00924898 Completed Phase 4 Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) January 2005 December 2013
NCT01154673 Completed Phase 2/Phase 3 Effects of Intensive cART During Acute/Early HIV Infection November 2011 September 2014
NCT01197027 Completed Phase 3 Feasibility and Acceptability Study of an Individual-Level Behavioral Intervention for Individuals With Acute and Early HIV-Infection February 2010 April 2012
NCT01369056 Completed N/A HAART Adherence Among HIV-infected Persons and the Factors Affecting Treatment Adherence July 2010 December 2011
NCT01434706 Completed N/A Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection September 16, 2010 April 7, 2015
NCT02170246 Completed Phase 1 Analysis of Telmisartan Administered With Antiretroviral Therapy (ART) in Patients With Acute HIV Infection January 28, 2015 June 13, 2018
NCT02614950 Completed N/A Viral Suppression After Analytic Treatment Interruption in Thai Patients Who Initiated Highly Active Antiretroviral Therapy During Acute HIV Infection February 2016 December 2016
NCT02750059 Completed Phase 2 Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis January 2015 February 2018
NCT02384395 Completed N/A Safety and Efficacy of Fixed Dose Combination Dolutegravir/Abacavir/Lamivudine FDC Initiated During Acute HIV Infection September 2015 September 17, 2021
NCT02467439 Completed N/A Acute Partner and Social Contact Referral: iKnow June 2015 May 2, 2019
NCT02470351 Completed Assessment of the HIV CNS Reservoir, Neurological and Neuro-cognitive Effects, and Source of Rebound HIV in CNS January 2015 March 2016
NCT02475915 Completed Phase 1/Phase 2 Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection January 2015 March 2016
NCT05719441 Not yet recruiting Phase 2 A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission June 15, 2024 September 6, 2028
NCT05728996 Recruiting Netherlands Cohort Study on Acute HIV Infection August 1, 2015 August 1, 2028
NCT00796146 Recruiting Establish and Characterize an Acute HIV Infection Cohort in a High Risk Population April 2009 July 2033
NCT00796263 Recruiting Phase 3 Antiretroviral Therapy for Acute and Chronic HIV Infection April 2009 June 2033
NCT00855413 Terminated Phase 4 HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine March 2009 November 2013
NCT02231281 Unknown status Phase 3 Early cART and cART in Combination With Autologous HIV-1 Specific Cytotoxic T Lymphocyte (CTL) Infusion in The Treatment of Acute HIV-1 Infected Adults August 2014 December 2018
MedGen concept unique identifier (MedGen Concept name)
C0343752
MedGen unique identifier (MedGen Concept name)
575808